SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020853
Filing Date
2023-05-11
Accepted
2023-05-11 07:50:58
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20230331.htm   iXBRL 10-Q 2804288
2 EX-31.1 gern-ex31_1.htm EX-31 20517
3 EX-31.2 gern-ex31_2.htm EX-31 20531
4 EX-32.1 gern-ex32_1.htm EX-32 10666
5 EX-32.2 gern-ex32_2.htm EX-32 10690
  Complete submission text file 0000950170-23-020853.txt   9510589

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20230331_def.xml EX-101.DEF 172661
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230331_lab.xml EX-101.LAB 402832
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20230331_cal.xml EX-101.CAL 46006
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230331.xsd EX-101.SCH 47455
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230331_pre.xml EX-101.PRE 279893
44 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230331_htm.xml XML 2078768
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 23908891
SIC: 2834 Pharmaceutical Preparations